145 related articles for article (PubMed ID: 8846233)
21. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
Niebrój-Dobosz I; Dziewulska D; Kwieciński H
Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evidence for neurofilament heavy subunit aggregation in motor neurons of spinal cords of patients with amyotrophic lateral sclerosis.
Mendonça DM; Chimelli L; Martinez AM
Braz J Med Biol Res; 2005 Jun; 38(6):925-33. PubMed ID: 15933787
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
[TBL] [Abstract][Full Text] [Related]
24. Identification of VGF nerve growth factor inducible-producing cells in human spinal cords and expression change in patients with amyotrophic lateral sclerosis.
Noda Y; Tanaka M; Nakamura S; Ito J; Kakita A; Hara H; Shimazawa M
Int J Med Sci; 2020; 17(4):480-489. PubMed ID: 32174778
[TBL] [Abstract][Full Text] [Related]
25. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?
Mendonça DM; Martins SC; Higashi R; Muscara MN; Neto VM; Chimelli L; Martinez AM
Amyotroph Lateral Scler; 2011 Mar; 12(2):144-7. PubMed ID: 21198418
[TBL] [Abstract][Full Text] [Related]
27. Histological changes in the rat brain and spinal cord following prolonged intracerebroventricular infusion of cerebrospinal fluid from amyotrophic lateral sclerosis patients are similar to those caused by the disease.
Gómez-Pinedo U; Galán L; Yañez M; Matias-Guiu J; Valencia C; Guerrero-Sola A; Lopez-Sosa F; Brin JR; Benito-Martin MS; Leon-Espinosa G; Vela-Souto A; Lendinez C; Guillamon-Vivancos T; Matias-Guiu JA; Arranz-Tagarro JA; Barcia JA; Garcia AG
Neurologia (Engl Ed); 2018 May; 33(4):211-223. PubMed ID: 27570180
[TBL] [Abstract][Full Text] [Related]
28. Motor neurons are rich in non-phosphorylated neurofilaments: cross-species comparison and alterations in ALS.
Tsang YM; Chiong F; Kuznetsov D; Kasarskis E; Geula C
Brain Res; 2000 Apr; 861(1):45-58. PubMed ID: 10751564
[TBL] [Abstract][Full Text] [Related]
29. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
[TBL] [Abstract][Full Text] [Related]
30. O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS).
Lüdemann N; Clement A; Hans VH; Leschik J; Behl C; Brandt R
J Biol Chem; 2005 Sep; 280(36):31648-58. PubMed ID: 16006557
[TBL] [Abstract][Full Text] [Related]
31. Glutamatergic receptors regulate expression, phosphorylation and accumulation of neurofilaments in spinal cord neurons.
Vartiainen N; Tikka T; Keinänen R; Chan PH; Koistinaho J
Neuroscience; 1999; 93(3):1123-33. PubMed ID: 10473276
[TBL] [Abstract][Full Text] [Related]
32. Effect of ALS IgG on motor neurons in organotypic spinal cord cultures.
Li B; Liu XY; Li Z; Bu H; Sun MM; Guo YS; Li CY
Can J Neurol Sci; 2008 May; 35(2):220-5. PubMed ID: 18574938
[TBL] [Abstract][Full Text] [Related]
33. [Gene expression profile of spinal ventral horn in ALS].
Yamamoto M; Tanaka F; Sobue G
Brain Nerve; 2007 Oct; 59(10):1129-39. PubMed ID: 17969353
[TBL] [Abstract][Full Text] [Related]
34. Spatial elucidation of spinal cord lipid- and metabolite- regulations in amyotrophic lateral sclerosis.
Hanrieder J; Ewing AG
Sci Rep; 2014 Jun; 4():5266. PubMed ID: 24919836
[TBL] [Abstract][Full Text] [Related]
35. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural evidence of neurofilament involvement in immune-mediated motor neuron injury.
Liu YL; Guo YS; Xu L; Wu SY; Wu DX; Yang C; Li CY
Neurol Res; 2008 Nov; 30(9):990-4. PubMed ID: 18662498
[TBL] [Abstract][Full Text] [Related]
37. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
[TBL] [Abstract][Full Text] [Related]
38. Expression of ciliary neurotrophic factor is maintained in spinal motor neurons of amyotrophic lateral sclerosis.
Schorr M; Zhou L; Schwechheimer K
J Neurol Sci; 1996 Sep; 140(1-2):117-22. PubMed ID: 8866436
[TBL] [Abstract][Full Text] [Related]
39. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord.
Ge WW; Leystra-Lantz C; Wen W; Strong MJ
J Biol Chem; 2003 Jul; 278(29):26558-63. PubMed ID: 12730211
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule-associated protein 2 (MAP2) antibodies.
Kikuchi H; Doh-ura K; Kawashima T; Kira J; Iwaki T
Acta Neuropathol; 1999 Jan; 97(1):13-21. PubMed ID: 9930890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
